• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Metabolism of immune cells in cancer.癌症中的免疫细胞代谢。
Nat Rev Cancer. 2020 Sep;20(9):516-531. doi: 10.1038/s41568-020-0273-y. Epub 2020 Jul 6.
2
Single-Cell Proteomics for Cancer Immunotherapy.单细胞蛋白质组学在癌症免疫治疗中的应用
Adv Cancer Res. 2018;139:185-207. doi: 10.1016/bs.acr.2018.04.006. Epub 2018 May 23.
3
Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy.肿瘤发生和抗肿瘤免疫治疗中的免疫代谢重编程。
Mol Cancer. 2022 Jan 21;21(1):27. doi: 10.1186/s12943-021-01486-5.
4
TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.TLR 介导的肿瘤微环境代谢重编程:癌症免疫治疗的潜在新策略。
Cell Mol Immunol. 2018 May;15(5):428-437. doi: 10.1038/cmi.2018.4. Epub 2018 Mar 19.
5
Immunometabolism: A new target for improving cancer immunotherapy.免疫代谢:改善癌症免疫疗法的新靶点。
Adv Cancer Res. 2019;143:195-253. doi: 10.1016/bs.acr.2019.03.004. Epub 2019 Apr 17.
6
Metabolic Modulation of Immunity: A New Concept in Cancer Immunotherapy.代谢免疫调节:癌症免疫治疗的新概念。
Cell Rep. 2020 Jul 7;32(1):107848. doi: 10.1016/j.celrep.2020.107848.
7
The cancer metabolic reprogramming and immune response.癌症代谢重编程与免疫应答。
Mol Cancer. 2021 Feb 5;20(1):28. doi: 10.1186/s12943-021-01316-8.
8
Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies.联合免疫检查点阻断的癌症治疗:机制与策略。
Immunity. 2018 Mar 20;48(3):417-433. doi: 10.1016/j.immuni.2018.03.007.
9
Innate and Adaptive Immune Cell Metabolism in Tumor Microenvironment.先天和适应性免疫细胞代谢在肿瘤微环境中的作用。
Adv Exp Med Biol. 2017;1011:211-223. doi: 10.1007/978-94-024-1170-6_7.
10
Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.肿瘤微环境与癌症和癌症干细胞中的代谢可塑性:耐药性卵巢癌干细胞中代谢和免疫调节特征的观点。
Semin Cancer Biol. 2018 Dec;53:265-281. doi: 10.1016/j.semcancer.2018.10.002. Epub 2018 Oct 11.

引用本文的文献

1
Dendritic cells: understanding ontogeny, subsets, functions, and their clinical applications.树突状细胞:了解其个体发育、亚群、功能及其临床应用。
Mol Biomed. 2025 Sep 8;6(1):62. doi: 10.1186/s43556-025-00300-8.
2
Plasma metabolites mediate the effects of circulating immune cell phenotypes on prostate cancer: A 2-step Mendelian randomization study.血浆代谢物介导循环免疫细胞表型对前列腺癌的影响:一项两步孟德尔随机化研究。
Medicine (Baltimore). 2025 Sep 5;104(36):e44282. doi: 10.1097/MD.0000000000044282.
3
Nanotechnology and natural killer cell immunotherapy: synergistic approaches for precise immune system adjustment and targeted cancer treatment in gastrointestinal tumors.纳米技术与自然杀伤细胞免疫疗法:胃肠道肿瘤中精确调节免疫系统和靶向癌症治疗的协同方法。
Front Med (Lausanne). 2025 Aug 21;12:1647737. doi: 10.3389/fmed.2025.1647737. eCollection 2025.
4
Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers.癌症中的氧化应激:从肿瘤与微环境重塑到治疗前沿
Mol Cancer. 2025 Aug 22;24(1):219. doi: 10.1186/s12943-025-02375-x.
5
Metabolism and epigenetics in cancer: toward personalized treatment.癌症中的代谢与表观遗传学:迈向个性化治疗
Front Endocrinol (Lausanne). 2025 Jul 25;16:1530578. doi: 10.3389/fendo.2025.1530578. eCollection 2025.
6
Research progress on the interaction between glucose metabolic reprogramming and lactylation in tumors.肿瘤中葡萄糖代谢重编程与乳酸化相互作用的研究进展
Front Immunol. 2025 Jul 14;16:1595162. doi: 10.3389/fimmu.2025.1595162. eCollection 2025.
7
Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy.免疫细胞重编程中的代谢检查点:为癌症治疗重新调整免疫代谢
Mol Cancer. 2025 Aug 2;24(1):210. doi: 10.1186/s12943-025-02407-6.
8
Integrating spatial omics and single-cell mass spectrometry imaging reveals tumor-host metabolic interplay in hepatocellular carcinoma.整合空间组学和单细胞质谱成像揭示肝细胞癌中肿瘤与宿主的代谢相互作用。
Proc Natl Acad Sci U S A. 2025 Aug 5;122(31):e2505789122. doi: 10.1073/pnas.2505789122. Epub 2025 Jul 29.
9
A Novel Hypoxia-Immune Signature for Gastric Cancer Prognosis and Immunotherapy: Insights from Bulk and Single-Cell RNA-Seq.一种用于胃癌预后和免疫治疗的新型缺氧-免疫特征:来自批量和单细胞RNA测序的见解
Curr Issues Mol Biol. 2025 Jul 16;47(7):552. doi: 10.3390/cimb47070552.
10
Metabolic reprogramming and functional crosstalk within the tumor microenvironment (TME) and A Multi-omics anticancer approach.肿瘤微环境(TME)中的代谢重编程与功能串扰以及多组学抗癌方法。
Med Oncol. 2025 Jul 24;42(9):373. doi: 10.1007/s12032-025-02945-5.

本文引用的文献

1
Mitochondrial TCA cycle metabolites control physiology and disease.线粒体三羧酸循环代谢物控制着生理和疾病。
Nat Commun. 2020 Jan 3;11(1):102. doi: 10.1038/s41467-019-13668-3.
2
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells.肿瘤内龛位维持并分化具有干细胞样特征的 CD8+T 细胞。
Nature. 2019 Dec;576(7787):465-470. doi: 10.1038/s41586-019-1836-5. Epub 2019 Dec 11.
3
Metabolic Profiling Using Stable Isotope Tracing Reveals Distinct Patterns of Glucose Utilization by Physiologically Activated CD8 T Cells.代谢谱分析利用稳定同位素示踪技术揭示了生理激活的 CD8 T 细胞对葡萄糖利用的不同模式。
Immunity. 2019 Nov 19;51(5):856-870.e5. doi: 10.1016/j.immuni.2019.09.003. Epub 2019 Oct 10.
4
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion.谷氨酰胺阻断诱导了不同的代谢程序来克服肿瘤免疫逃逸。
Science. 2019 Nov 22;366(6468):1013-1021. doi: 10.1126/science.aav2588. Epub 2019 Nov 7.
5
VISTA is an acidic pH-selective ligand for PSGL-1.VISTA 是 PSGL-1 的酸性 pH 选择性配体。
Nature. 2019 Oct;574(7779):565-570. doi: 10.1038/s41586-019-1674-5. Epub 2019 Oct 23.
6
Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy.靶向肿瘤内在己糖胺生物合成使胰腺癌对抗 PD-1 治疗敏感。
J Clin Invest. 2020 Jan 2;130(1):451-465. doi: 10.1172/JCI127515.
7
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy.限制糖酵解可维持 T 细胞效应功能并增强检查点疗法。
Cell Rep. 2019 Oct 1;29(1):135-150.e9. doi: 10.1016/j.celrep.2019.08.068.
8
Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells.人类非小细胞肺癌细胞中的代谢多样性。
Mol Cell. 2019 Dec 5;76(5):838-851.e5. doi: 10.1016/j.molcel.2019.08.028. Epub 2019 Sep 26.
9
GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH).GS-0976(非司他特):一种在研的肝靶向乙酰辅酶 A 羧化酶(ACC)抑制剂,用于治疗非酒精性脂肪性肝炎(NASH)。
Expert Opin Investig Drugs. 2020 Feb;29(2):135-141. doi: 10.1080/13543784.2020.1668374. Epub 2019 Sep 19.
10
Mechanisms and Implications of Metabolic Heterogeneity in Cancer.癌症代谢异质性的机制与意义。
Cell Metab. 2019 Sep 3;30(3):434-446. doi: 10.1016/j.cmet.2019.08.013.

癌症中的免疫细胞代谢。

Metabolism of immune cells in cancer.

机构信息

Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Research Center, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

Nat Rev Cancer. 2020 Sep;20(9):516-531. doi: 10.1038/s41568-020-0273-y. Epub 2020 Jul 6.

DOI:10.1038/s41568-020-0273-y
PMID:32632251
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8041116/
Abstract

Through the successes of checkpoint blockade and adoptive cellular therapy, immunotherapy has become an established treatment modality for cancer. Cellular metabolism has emerged as a critical determinant of the viability and function of both cancer cells and immune cells. In order to sustain prodigious anabolic needs, tumours employ a specialized metabolism that differs from untransformed somatic cells. This metabolism leads to a tumour microenvironment that is commonly acidic, hypoxic and/or depleted of critical nutrients required by immune cells. In this context, tumour metabolism itself is a checkpoint that can limit immune-mediated tumour destruction. Because our understanding of immune cell metabolism and cancer metabolism has grown significantly in the past decade, we are on the cusp of being able to unravel the interaction of cancer cell metabolism and immune metabolism in therapeutically meaningful ways. Although there are metabolic processes that are seemingly fundamental to both cancer and responding immune cells, metabolic heterogeneity and plasticity may serve to distinguish the two. As such, understanding the differential metabolic requirements of the diverse cells that comprise an immune response to cancer offers an opportunity to selectively regulate immune cell function. Such a nuanced evaluation of cancer and immune metabolism can uncover metabolic vulnerabilities and therapeutic windows upon which to intervene for enhanced immunotherapy.

摘要

通过检查点阻断和过继细胞疗法的成功,免疫疗法已成为癌症的一种既定治疗方法。细胞代谢已成为癌症细胞和免疫细胞存活和功能的关键决定因素。为了维持巨大的合成代谢需求,肿瘤采用了一种不同于未转化体细胞的特殊代谢方式。这种代谢导致肿瘤微环境通常呈酸性、缺氧和/或缺乏免疫细胞所需的关键营养物质。在这种情况下,肿瘤代谢本身就是一个检查点,可以限制免疫介导的肿瘤破坏。由于我们在过去十年中对免疫细胞代谢和癌症代谢的理解有了显著的提高,我们即将能够以有治疗意义的方式揭示癌细胞代谢和免疫代谢的相互作用。尽管有一些代谢过程似乎对癌症和反应性免疫细胞都是基本的,但代谢异质性和可塑性可能有助于区分两者。因此,了解构成对癌症免疫反应的不同细胞的差异代谢需求,为选择性调节免疫细胞功能提供了机会。对癌症和免疫代谢的这种细致评估,可以揭示代谢脆弱性和治疗窗口,从而增强免疫治疗效果。